| # | Drug | Count |
|---|---|---|
| 0 | REMDESIVIR | 6 |
| 1 | ACETAMINOPHEN | 5 |
| 2 | ADO-TRASTUZUMAB EMTANSINE | 4 |
| 3 | OCRELIZUMAB | 4 |
| 4 | OXALIPLATIN | 4 |
| 5 | ACETAMINOPHEN 500MG | 3 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 3 |
| 7 | PAIN RELIEVER | 3 |
| 8 | RITUXIMAB | 3 |
| 9 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CHLORIDE 0.65% | 1 | 0.0007 |
| 1 | ADO-TRASTUZUMAB EMTANSINE | 4 | 0.0005 |
| 2 | REMDESIVIR | 6 | 0.0005 |
| 3 | IOPROMIDE | 1 | 0.0002 |
| 4 | APREPITANT | 1 | 0.0001 |
| 5 | IRON SUCROSE | 1 | 0.0001 |
| 6 | GRANISETRON HYDROCHLORIDE | 1 | 0.0001 |
| 7 | GRANISETRON | 1 | 0.0001 |
| 8 | REGORAFENIB | 1 | 0.0001 |
| 9 | OCRELIZUMAB | 4 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human C1 Esterase Inhibitor [EPC] | 2 | 0.0005 |
| 1 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 6 | 0.0005 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 4 | Radiographic Contrast Agent [EPC] | 1 | 0.0000 |
| 5 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 4 | 0.0000 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 4 | 0.0000 |